Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atrial fibrillation
MedTech
Medtronic nets Japan approval for pulsed field ablation system
The PulseSelect system aims to treat the world’s most common irregular heart rhythm, atrial fibrillation.
Conor Hale
May 13, 2024 11:25am
J&J brings AI update to its heart-mapping Carto 3 system
May 8, 2024 10:15am
Apple Watch's AFib History certified by FDA for clinical studies
May 6, 2024 9:40am
Abbott nets European approval for 6-year cardiac monitor implant
Mar 26, 2024 12:49pm
Haemonetics nabs ablation safety developer Attune in $160M deal
Mar 5, 2024 12:57pm
J&J nets CE mark for Varipulse pulsed field ablation system
Feb 29, 2024 10:33am